We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+6.12%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$556B
AUM Growth
+$22.5B
Cap. Flow
-$5B
Cap. Flow %
-0.9%
Top 10 Hldgs %
17.58%
Holding
2,638
New
69
Increased
1,185
Reduced
969
Closed
83

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$1.8B
2
TSLA icon
Tesla
TSLA
+$1.74B
3
NXPI icon
NXP Semiconductors
NXPI
+$1.24B
4
DHR icon
Danaher
DHR
+$1.21B
5
BKNG icon
Booking.com
BKNG
+$1.09B

Sector Composition

Rank Sector Weight
1 Healthcare 17.78%
2 Financials 16.36%
3 Consumer Discretionary 14.69%
4 Technology 14.23%
5 Industrials 9.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INN
2376
Summit Hotel Properties
INN
$651M
$201K ﹤0.01%
10,787
-2,053
-16% -$35.8K
MTRX icon
2377
Matrix Service
MTRX
$330M
$201K ﹤0.01%
21,483
WMGIZ
2378
DELISTED
Wright Medical Group, Inc. Contingent Value Right
WMGIZ
$201K ﹤0.01%
132,507
FC icon
2379
Franklin Covey
FC
$235M
$199K ﹤0.01%
10,332
XCRA
2380
DELISTED
Xcerra Corporation
XCRA
$199K ﹤0.01%
20,345
QHC
2381
DELISTED
Quorum Health Corporation
QHC
$197K ﹤0.01%
47,513
+1,818
+4% +$7.46K
IMGN
2382
DELISTED
Immunogen Inc
IMGN
$196K ﹤0.01%
27,636
+36
+0.1% +$165
WLL
2383
DELISTED
Whiting Petroleum Corporation
WLL
$195K ﹤0.01%
118
+1
+0.9% +$2.28K
VICR icon
2384
Vicor
VICR
$9.72B
$194K ﹤0.01%
10,845
SPPI
2385
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$194K ﹤0.01%
26,016
-1,184
-4% -$7.74K
WMC
2386
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$193K ﹤0.01%
1,874
+460
+33% +$47.2K
GIFI
2387
DELISTED
Gulf Island Fabrication
GIFI
$188K ﹤0.01%
16,238
+38
+0.2% +$382
EPE
2388
DELISTED
EP Energy Corporation
EPE
$187K ﹤0.01%
51,007
+4,300
+9% +$18.8K
GNCA
2389
DELISTED
Genocea Biosciences, Inc.
GNCA
$187K ﹤0.01%
4,486
+1,504
+50% +$72.4K
AREX
2390
DELISTED
Approach Resources Inc.
AREX
$185K ﹤0.01%
55,021
+30,021
+120% +$78.1K
SNMX
2391
DELISTED
Senomyx, Inc.
SNMX
$184K ﹤0.01%
221,205
-20,000
-8% -$17.7K
GPRO icon
2392
GoPro
GPRO
$107M
$183K ﹤0.01%
22,478
ACTA
2393
DELISTED
Actua Corp
ACTA
$180K ﹤0.01%
12,800
PLUG icon
2394
Plug Power
PLUG
$3.1B
$179K ﹤0.01%
87,650
+9,950
+13% +$20.8K
VCYT icon
2395
Veracyte
VCYT
$3.73B
$179K ﹤0.01%
21,492
-4,349
-17% -$35.5K
ATEN icon
2396
A10 Networks
ATEN
$1.97B
$177K ﹤0.01%
21,022
DWSN icon
2397
Dawson Geophysical
DWSN
$138M
$176K ﹤0.01%
47,099
+4,141
+10% +$18.1K
ITCI
2398
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$176K ﹤0.01%
14,136
-469,175
-97% -$5.44M
EVC icon
2399
Entravision Communication
EVC
$850M
$175K ﹤0.01%
26,500
CWEN.A
2400
DELISTED
Clearway Energy Class A
CWEN.A
$174K ﹤0.01%
10,200

Similar funds

T. Rowe Price Associates's Q2 2017 Portfolio in Review

As of Q2 2017, T. Rowe Price Associates held 2,638 positions worth $556B, up 4.2% from $534B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

T. Rowe Price Associates's Q2 2017 filing shows 69 new, 1,185 increased, 969 reduced and 83 closed positions. Its largest new stake was Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6: 15,513,011 shares worth $844M. The largest sale was Amazon, an estimated $1.8B.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2017 buy was Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6: 15,513,011 shares worth $844M.
  • T. Rowe Price Associates added most to Becton Dickinson in Q2 2017, an estimated $2.34B increase.
  • T. Rowe Price Associates's biggest Q2 2017 reduction was Amazon, cutting an estimated $1.8B.
  • T. Rowe Price Associates fully exited Yahoo Inc in Q2 2017, selling an estimated $362M.
  • T. Rowe Price Associates's ten largest holdings make up 18% of its $556B portfolio in Q2 2017.
  • T. Rowe Price Associates opened 69 new positions and closed 83 in Q2 2017.
  • T. Rowe Price Associates's portfolio value rose 4.2% quarter-over-quarter to $556B.

Based on T. Rowe Price Associates's 13F filing for Q2 2017, filed 14 Aug 2017.